SE0102616D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0102616D0 SE0102616D0 SE0102616A SE0102616A SE0102616D0 SE 0102616 D0 SE0102616 D0 SE 0102616D0 SE 0102616 A SE0102616 A SE 0102616A SE 0102616 A SE0102616 A SE 0102616A SE 0102616 D0 SE0102616 D0 SE 0102616D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel compounds
- therapy
- processes
- formula
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
Priority Applications (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102616A SE0102616D0 (sv) | 2001-07-25 | 2001-07-25 | Novel compounds |
CA2454703A CA2454703C (en) | 2001-07-25 | 2002-07-19 | Novel thiophene carboxamide derivatives |
DE60237828T DE60237828D1 (de) | 2001-07-25 | 2002-07-19 | Neue verbindungen |
AT02751935T ATE482944T1 (de) | 2001-07-25 | 2002-07-19 | Neue verbindungen |
DK02751935.4T DK1421074T3 (da) | 2001-07-25 | 2002-07-19 | Nye forbindelser |
ES02751935T ES2351436T3 (es) | 2001-07-25 | 2002-07-19 | Nuevos compuestos. |
CNB028158369A CN1263751C (zh) | 2001-07-25 | 2002-07-19 | 新化合物 |
EP02751935A EP1421074B1 (en) | 2001-07-25 | 2002-07-19 | Novel compounds |
BR0211473-9A BR0211473A (pt) | 2001-07-25 | 2002-07-19 | Novos compostos |
NZ530750A NZ530750A (en) | 2001-07-25 | 2002-07-19 | Novel thiophene carboxamide compounds and their use as pharmaceuticals |
IL16002802A IL160028A0 (en) | 2001-07-25 | 2002-07-19 | Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions containing them and their use in therapy |
PT02751935T PT1421074E (pt) | 2001-07-25 | 2002-07-19 | Novos compostos |
US10/484,569 US7125896B2 (en) | 2001-07-25 | 2002-07-19 | Thiophene carboxamide compounds as inhibitors of enzyme IKK-2 |
PCT/SE2002/001403 WO2003010158A1 (en) | 2001-07-25 | 2002-07-19 | Novel compounds |
KR1020047001154A KR100931172B1 (ko) | 2001-07-25 | 2002-07-19 | 신규 화합물 |
JP2003515517A JP4571800B2 (ja) | 2001-07-25 | 2002-07-19 | 新規化合物 |
MXPA04000756A MXPA04000756A (es) | 2001-07-25 | 2002-07-19 | Nuevos compuestos. |
AU2002355245A AU2002355245B2 (en) | 2001-07-25 | 2002-07-19 | Novel compounds |
ZA200400492A ZA200400492B (en) | 2001-07-25 | 2004-01-22 | Novel compounds. |
IL160028A IL160028A (en) | 2001-07-25 | 2004-01-22 | Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy |
NO20040313A NO326684B1 (no) | 2001-07-25 | 2004-01-23 | Nye tiofenkarboksamidderivater, fremgangsmåte for fremstilling derav, farmasøytiske sammensetninger som inneholder slike derivater, samt deres anvendelse ved terapi |
HK05103629A HK1071129A1 (en) | 2001-07-25 | 2005-04-27 | Novel compounds |
US11/516,225 US7956084B2 (en) | 2001-07-25 | 2006-09-06 | Phenyl thiophene carboxamide compounds as inhibitors of the enzyme IKK-2 |
CY20101101069T CY1111543T1 (el) | 2001-07-25 | 2010-11-25 | Νεες ενωσεις |
US12/977,640 US20110152234A1 (en) | 2001-07-25 | 2010-12-23 | Novel Compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102616A SE0102616D0 (sv) | 2001-07-25 | 2001-07-25 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0102616D0 true SE0102616D0 (sv) | 2001-07-25 |
Family
ID=20284944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0102616A SE0102616D0 (sv) | 2001-07-25 | 2001-07-25 | Novel compounds |
Country Status (22)
Country | Link |
---|---|
US (3) | US7125896B2 (sv) |
EP (1) | EP1421074B1 (sv) |
JP (1) | JP4571800B2 (sv) |
KR (1) | KR100931172B1 (sv) |
CN (1) | CN1263751C (sv) |
AT (1) | ATE482944T1 (sv) |
AU (1) | AU2002355245B2 (sv) |
BR (1) | BR0211473A (sv) |
CA (1) | CA2454703C (sv) |
CY (1) | CY1111543T1 (sv) |
DE (1) | DE60237828D1 (sv) |
DK (1) | DK1421074T3 (sv) |
ES (1) | ES2351436T3 (sv) |
HK (1) | HK1071129A1 (sv) |
IL (2) | IL160028A0 (sv) |
MX (1) | MXPA04000756A (sv) |
NO (1) | NO326684B1 (sv) |
NZ (1) | NZ530750A (sv) |
PT (1) | PT1421074E (sv) |
SE (1) | SE0102616D0 (sv) |
WO (1) | WO2003010158A1 (sv) |
ZA (1) | ZA200400492B (sv) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0003154D0 (en) * | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
AP1753A (en) * | 2001-06-11 | 2007-07-18 | Shire Biochem Inc | Thiophene derivatives as antiviral agents for flavvivirus infection |
US8329924B2 (en) * | 2001-06-11 | 2012-12-11 | Vertex Pharmaceuticals (Canada) Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
MXPA04004064A (es) * | 2001-10-30 | 2004-09-06 | Pharmacia Corp | Derivados heteroaromaticos de carboxamida para el tratramiento de la inflamacion. |
JP2005531608A (ja) * | 2002-06-06 | 2005-10-20 | スミスクライン・ビーチャム・コーポレイション | NF−κB阻害剤 |
CA2502429A1 (en) | 2002-10-31 | 2004-05-21 | Amgen Inc. | Antiinflammation agents |
AU2003300832A1 (en) * | 2002-12-06 | 2004-06-30 | Smithkline Beecham Corporation | NF-KappaB INHIBITORS |
KR101058696B1 (ko) * | 2002-12-10 | 2011-08-22 | 바이로켐 파마 인코포레이티드 | 후라비바이러스 감염의 치료 또는 예방을 위한 화합물과방법 |
SE0300091D0 (sv) | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
SE0300092D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
US7595316B2 (en) * | 2003-06-27 | 2009-09-29 | Banyu Pharmaceutical Co., Ltd. | Heteroaryloxy nitrogenous saturated heterocyclic derivative |
US7423061B2 (en) * | 2003-08-15 | 2008-09-09 | Astrazeneca Ab | Substitute thiophenes and uses thereof |
DE602004019687D1 (de) * | 2003-12-23 | 2009-04-09 | Somanta Ltd | Anthraquinonderivate als mittel gegen krebs |
GB0403744D0 (en) * | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
WO2005105777A1 (en) * | 2004-05-05 | 2005-11-10 | Pharmacia & Upjohn Company Llc | Substituted thiophene amide compounds for the treatment of inflammation |
TW200616967A (en) | 2004-06-24 | 2006-06-01 | Smithkline Beecham Corp | Novel indazole carboxamides and their use |
PE20060748A1 (es) | 2004-09-21 | 2006-10-01 | Smithkline Beecham Corp | Derivados de indolcarboxamida como inhibidores de quinasa ikk2 |
DE602006003661D1 (de) | 2005-06-06 | 2008-12-24 | Lilly Co Eli | Ampa-rezeptoren-verstärker |
DE102005029382B3 (de) * | 2005-06-24 | 2006-12-21 | Sanofi-Aventis Deutschland Gmbh | Alkoxymethylyl-substituierte Benzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
WO2007005534A2 (en) | 2005-06-30 | 2007-01-11 | Smithkline Beecham Corporation | Chemical compounds |
KR20080052650A (ko) * | 2005-09-07 | 2008-06-11 | 라보라토리스 세로노 에스.에이. | 자궁내막증 치료용 ikk 저해제 |
PT1976828T (pt) | 2005-12-29 | 2017-03-10 | Celtaxsys Inc | Derivados de diamina como inibidores de leucotrieno a4 hidrolase |
WO2008002246A1 (en) * | 2006-06-28 | 2008-01-03 | Astrazeneca Ab | A pharmaceutical composition comprising an ikk2 inhibitor and a second active ingrdient. |
ES2372707T3 (es) * | 2006-11-01 | 2012-01-25 | Chroma Therapeutics Limited | Inhibidores de la ikk-beta serina-treonina proteína quinasa. |
WO2008053185A1 (en) * | 2006-11-01 | 2008-05-08 | Chroma Therapeutics Ltd. | INHIBITORS OF IKK-β SERINE-THREONINE PROTEIN KINASE |
PL2104674T3 (pl) | 2006-11-15 | 2013-12-31 | Vertex Pharmaceuticals Canada Incorporated | Analogi tiofenu do leczenia lub zapobiegania zakażeniom flawiwirusowym |
PL2119703T3 (pl) * | 2007-01-15 | 2013-04-30 | Santen Pharmaceutical Co Ltd | Nowe pochodne indolu o aktywności hamującej kinazę-ßIκB |
PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
JP2011518817A (ja) * | 2008-04-26 | 2011-06-30 | クロマ セラピューティクス リミテッド | IKK−βセリン−、スレオニン−プロテインキナーゼ阻害剤としての置換されたチオフェンカルボキシアミド類 |
CA2727928A1 (en) * | 2008-06-18 | 2009-12-23 | Merck Sharp & Dohme Corp. | Inhibitors of janus kinases |
RU2503661C2 (ru) * | 2008-07-14 | 2014-01-10 | Сантен Фармасьютикал Ко., Лтд. | Новое производное индола, содержащее карбамоильную группу, уреидную группу и замещенную оксигруппу |
KR101323448B1 (ko) | 2008-10-02 | 2013-11-27 | 아사히 가세이 파마 가부시키가이샤 | 8위 치환 이소퀴놀린 유도체 및 이의 용도 |
US8354539B2 (en) | 2009-03-10 | 2013-01-15 | Glaxo Group Limited | Indole derivatives as IKK2 inhibitors |
US8410163B2 (en) * | 2009-04-16 | 2013-04-02 | Telik, Inc. | Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitors |
GB0913345D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | New combination 802 |
WO2011030139A1 (en) | 2009-09-11 | 2011-03-17 | Astrazeneca Ab | 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators |
WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
CN101812007B (zh) * | 2010-04-27 | 2011-11-23 | 浙江大学 | 氨基吡咯类化合物及其制备方法 |
GB201016912D0 (en) | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
WO2012046793A1 (ja) * | 2010-10-07 | 2012-04-12 | 参天製薬株式会社 | ウレイド基とアミノカルボニル基を置換基として有するチオフェン誘導体を有効成分として含有する新規jak3阻害剤 |
GB201021992D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | Compound |
GB201021979D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | New compound |
KR102220242B1 (ko) * | 2012-03-14 | 2021-02-25 | 머크 샤프 앤드 돔 코포레이션 | Cgrp 수용체 길항제의 제조 방법 |
US9487523B2 (en) | 2012-03-14 | 2016-11-08 | Merck Sharp & Dohme Corp. | Process for making CGRP receptor antagonists |
ES2864862T3 (es) | 2013-03-12 | 2021-10-14 | Celltaxis Llc | Métodos de inhibición de la leucotrieno A4 hidrolasa |
BR112015022864A8 (pt) | 2013-03-14 | 2019-11-26 | Celtaxsys Inc | composto, composição farmacêutica e uso dos mesmos |
KR20150127245A (ko) | 2013-03-14 | 2015-11-16 | 켈탁시스, 인코퍼레이티드 | 류코트라이엔 a4 가수분해효소의 저해제 |
CA2906086A1 (en) | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
EP2821791A1 (en) * | 2013-07-04 | 2015-01-07 | Université de Strasbourg | 3-aryl propiolonitrile compounds for thiol labeling |
LT3057969T (lt) | 2013-10-17 | 2018-07-10 | Blueprint Medicines Corporation | Kompozicijos, naudojamos gydyti sutrikimams, susijusiems su kit |
JP6344923B2 (ja) * | 2014-01-29 | 2018-06-20 | 株式会社Uacj | 高強度アルミニウム合金及びその製造方法 |
WO2015169130A1 (zh) * | 2014-05-09 | 2015-11-12 | 上海科胜药物研发有限公司 | 新的沃替西汀中间体及其合成方法 |
WO2018183712A1 (en) | 2017-03-31 | 2018-10-04 | Blueprint Medicines Corporation | Pyrrolo[1,2-b]pyridazine compounds and compositions useful for treating disorders related to kit and pdgfr |
EP3801559A4 (en) | 2018-05-31 | 2022-03-02 | Celltaxis, LLC | METHOD FOR REDUCING LUNG EXACERBATIONS IN PATIENTS SUFFERING FROM RESPIRATORY DISEASE |
KR20220025704A (ko) | 2019-04-12 | 2022-03-03 | 블루프린트 메디신즈 코포레이션 | Kit- 및 pdgfra 매개성 질환을 치료하기 위한 피롤로트리아진 유도체 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1468012A (en) * | 1973-08-09 | 1977-03-23 | Beecham Group Ltd | 2-amino-3-carboxy-thiophene derivatives |
DE3529247A1 (de) | 1985-05-17 | 1986-11-20 | Bayer Ag, 5090 Leverkusen | Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung |
GB2195634B (en) * | 1986-10-01 | 1990-08-15 | Roussel Lab Ltd | Thiophene derivatives |
JPH02193990A (ja) * | 1989-01-20 | 1990-07-31 | Taisho Pharmaceut Co Ltd | チオフェンカルボン酸誘導体 |
US5258357A (en) * | 1989-10-07 | 1993-11-02 | Basf Aktiengesellschaft | Carboxamides, their preparation and their use as herbicides |
US5378703A (en) * | 1990-04-09 | 1995-01-03 | Alcon Laboratories, Inc. | Sulfonamides useful as carbonic anhydrase inhibitors |
US5571810A (en) * | 1990-06-11 | 1996-11-05 | Fujisawa Pharmaceutical Co., Ltd. | Thiophene derivatives |
US5514801A (en) * | 1992-12-29 | 1996-05-07 | Monsanto Company | Cyclic sulfone containing retroviral protease inhibitors |
JPH09194476A (ja) * | 1996-01-12 | 1997-07-29 | Taisho Pharmaceut Co Ltd | チオフェンアルカン酸誘導体 |
EP0912548A1 (en) | 1996-07-11 | 1999-05-06 | Pfizer Inc. | Pyridylpyrrole compounds useful as interleukin- and tnf antagonists |
PT853083E (pt) * | 1997-01-06 | 2001-12-28 | Pfizer | Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica |
US6809088B2 (en) * | 1997-03-24 | 2004-10-26 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
WO1998046588A2 (en) * | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
US6037340A (en) | 1997-05-28 | 2000-03-14 | Cadus Pharmaceutical Corporation | Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds |
DE19744026A1 (de) | 1997-10-06 | 1999-04-08 | Hoechst Marion Roussel De Gmbh | Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln |
WO1999046244A1 (en) | 1998-03-12 | 1999-09-16 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
US20020002199A1 (en) * | 1998-03-12 | 2002-01-03 | Lone Jeppesen | Modulators of protein tyrosine phosphatases (ptpases) |
ES2251200T3 (es) * | 1998-07-08 | 2006-04-16 | Sanofi-Aventis Deutschland Gmbh | N-arilamidas del acido sulfonilaminocarboxilico sustituidas con azufre, su uso y preparaciones farmaceuticas que las comprenden. |
HN2000000051A (es) * | 1999-05-19 | 2001-02-02 | Pfizer Prod Inc | Derivados heterociclicos utiles como agentes anticancerosos |
GB0003154D0 (en) * | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
IL151946A0 (en) * | 2000-03-29 | 2003-04-10 | Cyclacel Ltd | 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
US6414013B1 (en) * | 2000-06-19 | 2002-07-02 | Pharmacia & Upjohn S.P.A. | Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
US20040024047A1 (en) * | 2001-10-12 | 2004-02-05 | Callahan James F. | Nf-kb inhibitors |
EP1324759A4 (en) | 2000-10-12 | 2004-05-12 | Smithkline Beecham Corp | NF - G (K) B INHIBITORS |
US7122544B2 (en) | 2000-12-06 | 2006-10-17 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
US6713638B2 (en) * | 2001-05-18 | 2004-03-30 | Joel M. Linden | 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors |
AP1753A (en) * | 2001-06-11 | 2007-07-18 | Shire Biochem Inc | Thiophene derivatives as antiviral agents for flavvivirus infection |
SE0102616D0 (sv) | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
SE0102617D0 (sv) | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
WO2003028731A1 (en) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Chk1 kinase inhibitors |
ATE414697T1 (de) * | 2001-10-04 | 2008-12-15 | Smithkline Beecham Corp | Nf-kb-inhibitoren |
WO2003029241A1 (en) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Chk1 kinase inhibitors |
TWI281916B (en) * | 2001-10-25 | 2007-06-01 | Lilly Co Eli | Antitumor compounds and methods |
US6835745B2 (en) * | 2002-01-15 | 2004-12-28 | Wyeth | Phenyl substituted thiophenes as estrogenic agents |
US7196106B2 (en) * | 2002-11-05 | 2007-03-27 | Merck & Co., Inc | Cyanothiophene derivatives, compositions containing such compounds and methods of use |
SE0300091D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
SE0300092D0 (sv) | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
-
2001
- 2001-07-25 SE SE0102616A patent/SE0102616D0/sv unknown
-
2002
- 2002-07-19 AT AT02751935T patent/ATE482944T1/de active
- 2002-07-19 DE DE60237828T patent/DE60237828D1/de not_active Expired - Lifetime
- 2002-07-19 MX MXPA04000756A patent/MXPA04000756A/es active IP Right Grant
- 2002-07-19 PT PT02751935T patent/PT1421074E/pt unknown
- 2002-07-19 AU AU2002355245A patent/AU2002355245B2/en not_active Ceased
- 2002-07-19 IL IL16002802A patent/IL160028A0/xx unknown
- 2002-07-19 JP JP2003515517A patent/JP4571800B2/ja not_active Expired - Fee Related
- 2002-07-19 CA CA2454703A patent/CA2454703C/en not_active Expired - Fee Related
- 2002-07-19 DK DK02751935.4T patent/DK1421074T3/da active
- 2002-07-19 WO PCT/SE2002/001403 patent/WO2003010158A1/en active IP Right Grant
- 2002-07-19 BR BR0211473-9A patent/BR0211473A/pt not_active Application Discontinuation
- 2002-07-19 US US10/484,569 patent/US7125896B2/en not_active Expired - Fee Related
- 2002-07-19 ES ES02751935T patent/ES2351436T3/es not_active Expired - Lifetime
- 2002-07-19 EP EP02751935A patent/EP1421074B1/en not_active Expired - Lifetime
- 2002-07-19 KR KR1020047001154A patent/KR100931172B1/ko not_active IP Right Cessation
- 2002-07-19 NZ NZ530750A patent/NZ530750A/en not_active IP Right Cessation
- 2002-07-19 CN CNB028158369A patent/CN1263751C/zh not_active Expired - Fee Related
-
2004
- 2004-01-22 IL IL160028A patent/IL160028A/en not_active IP Right Cessation
- 2004-01-22 ZA ZA200400492A patent/ZA200400492B/en unknown
- 2004-01-23 NO NO20040313A patent/NO326684B1/no not_active IP Right Cessation
-
2005
- 2005-04-27 HK HK05103629A patent/HK1071129A1/xx not_active IP Right Cessation
-
2006
- 2006-09-06 US US11/516,225 patent/US7956084B2/en not_active Expired - Fee Related
-
2010
- 2010-11-25 CY CY20101101069T patent/CY1111543T1/el unknown
- 2010-12-23 US US12/977,640 patent/US20110152234A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CY1111543T1 (el) | 2015-08-05 |
DE60237828D1 (de) | 2010-11-11 |
WO2003010158A1 (en) | 2003-02-06 |
EP1421074A1 (en) | 2004-05-26 |
MXPA04000756A (es) | 2004-04-20 |
HK1071129A1 (en) | 2005-07-08 |
BR0211473A (pt) | 2004-10-26 |
DK1421074T3 (da) | 2010-12-13 |
ATE482944T1 (de) | 2010-10-15 |
ZA200400492B (en) | 2005-04-22 |
CA2454703A1 (en) | 2003-02-06 |
NO326684B1 (no) | 2009-01-26 |
KR100931172B1 (ko) | 2009-12-11 |
US20110152234A1 (en) | 2011-06-23 |
US7125896B2 (en) | 2006-10-24 |
EP1421074B1 (en) | 2010-09-29 |
US20040242573A1 (en) | 2004-12-02 |
CA2454703C (en) | 2011-01-04 |
CN1541214A (zh) | 2004-10-27 |
NO20040313L (no) | 2004-03-25 |
US7956084B2 (en) | 2011-06-07 |
AU2002355245B2 (en) | 2008-05-15 |
KR20040018520A (ko) | 2004-03-03 |
IL160028A0 (en) | 2004-06-20 |
PT1421074E (pt) | 2010-11-29 |
JP4571800B2 (ja) | 2010-10-27 |
IL160028A (en) | 2012-01-31 |
CN1263751C (zh) | 2006-07-12 |
JP2005503372A (ja) | 2005-02-03 |
ES2351436T3 (es) | 2011-02-04 |
US20070015819A1 (en) | 2007-01-18 |
NZ530750A (en) | 2005-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0102616D0 (sv) | Novel compounds | |
MXPA04000755A (es) | Nuevos compuestos. | |
GB0003154D0 (en) | Novel compounds | |
HK1082250A1 (en) | Thiophene carboxamides as inhibitors of the enzymeikk-2 | |
SE0102439D0 (sv) | New compounds | |
SE0302811D0 (sv) | Novel compounds | |
SE0104140D0 (sv) | Novel Compounds | |
SE0202133D0 (sv) | Novel compounds | |
SE0300092D0 (sv) | Novel compounds | |
SE0302116D0 (sv) | Novel compounds | |
SE0302139D0 (sv) | Novel compounds | |
SE0100569D0 (sv) | New compounds | |
SE0303541D0 (sv) | New compounds | |
SE0101038D0 (sv) | Novel compounds | |
SE0303280D0 (sv) | Novel compounds | |
SE0303090D0 (sv) | Novel compounds | |
SE0302755D0 (sv) | Novel compounds | |
SE0002330D0 (sv) | Novel compounds | |
SE0004480D0 (sv) | Novel compounds |